Literature DB >> 14759512

PPARgamma mediates NSAIDs-induced upregulation of TFF2 expression in gastric epithelial cells.

Tadahito Shimada1, Ayako Koitabashi, Yoichiro Fujii, Takashi Hashimoto, Kumi Hosaka, Kyoko Tabei, Takashi Namatame, Masashi Yoneda, Hideyuki Hiraishi, Akira Terano.   

Abstract

Trefoil factor family (TFF) is a group of peptides that play critical roles in maintaining gastric mucosal integrity. In real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) and reporter gene assays, we show that indomethacin and aspirin upregulate TFF2 expression in MKN45 gastric cells. These drugs also activated peroxisome proliferator-activated receptor gamma (PPARgamma) at concentration ranges that increase TFF2 expression, and upregulated TFF2 expression was suppressed by GW9662, a specific inhibitor of PPARgamma. These results suggest that indomethacin and aspirin upregulate gastric expression of TFF2 through activation of PPARgamma. This mechanism may be important in reducing the extent of gastric mucosal injury caused by the administration of non-steroidal anti-inflammatory drugs (NSAIDs).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759512     DOI: 10.1016/S0014-5793(03)01527-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARγ and PPARα.

Authors:  Zheng Wang; Debby Koonen; Marten Hofker; Zhijun Bao
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

2.  Treatment effects of Shilajit on aspirin-induced gastric lesions in rats.

Authors:  Naghmeh Ghasemkhani; Aidin Shojaee Tabrizi; Fatemeh Namazi; Saeed Nazifi
Journal:  Physiol Rep       Date:  2021-04

Review 3.  Antiulcer Effect of Honey in Nonsteroidal Anti-Inflammatory Drugs Induced Gastric Ulcer Model in Rats: A Systematic Review.

Authors:  Annuar Fazalda; Adam Quraisiah; Mohd Fahami Nur Azlina
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-15       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.